Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Addus HomeCareADUS +0.39%94 EV-to-EBITDA is 13.19 as of Jul. 23, 2026, which is 28% below its 10-year median of 18.27. GuruFocus rates ADUS with a GF Score™ of 94/100 and a GF Value™ of $123.98 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 506 Healthcare Providers & Services companies, Addus HomeCare ranks worse than 57.91% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Addus HomeCare's enterprise value is $2,125 Mil.
Addus HomeCare's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was $161 Mil. Therefore, Addus HomeCare's EV-to-EBITDA for today is 13.19.
The historical rank and industry rank for Addus HomeCare's EV-to-EBITDA or its related term are showing as below:
ADUS'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 10.31 Med: 18.27 Max: 37.46
Current: 13.19
During the past 13 years, the highest EV-to-EBITDA of Addus HomeCare was 37.46. The lowest was 10.31. And the median was 18.27.
ADUS's EV-to-EBITDA is ranked worse than 57.91% of 506
companies
in the Healthcare Providers & Services industry
Industry Median: 10.96
vs ADUS: 13.19
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Addus HomeCare's PE Ratio (TTM) for today is calculated as:
Addus HomeCare's share price for today is $112.08.
Addus HomeCare's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $5.408.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
The historical data trend for Addus HomeCare's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Addus HomeCare's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Addus HomeCare EV-to-EBITDA vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Addus HomeCare's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Addus HomeCare's EV-to-EBITDA falls into.
Addus HomeCare's current Enterprise Value is $2,125 Mil.
Addus HomeCare's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $161 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Addus HomeCare (ADUS) has a EV-to-EBITDA of 13.19 as of Jul. 23, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Addus HomeCare. This is 28% below median its historical median of 18.27. Over the past decade, Addus HomeCare's EV-to-EBITDA has ranged from 10.31 to 37.46. According to the industry distribution chart, Addus HomeCare ranks #293 out of 506 companies in the Healthcare Providers & Services industry, placing it in the top 57.9%.
Is Addus HomeCare's EV-to-EBITDA too high?
Addus HomeCare's current EV-to-EBITDA of 13.19 is 28% below median its 10-year median of 18.27. Over the past 10 years, this metric has ranged from a low of 10.31 to a high of 37.46. The Healthcare Providers & Services industry median EV-to-EBITDA is 10.96. Addus HomeCare's value of 13.19 is 20.3% above this industry median. Based on the distribution chart, Addus HomeCare ranks #293 out of 506 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Addus HomeCare has a GF Score™ of 94/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Addus HomeCare's EV-to-EBITDA compare to SNDA and AVAH?
According to the Healthcare Providers & Services industry distribution chart, Addus HomeCare ranks #293 out of 506 companies for EV-to-EBITDA. This places Addus HomeCare in the lower half of its industry. The industry median EV-to-EBITDA is 10.96. Addus HomeCare's value of 13.19 is 20.3% above this benchmark. Historically, Addus HomeCare's own EV-to-EBITDA has ranged from 10.31 to 37.46 over the past decade. While the company's 10-year median is 18.27 vs. the industry median of 10.96, Addus HomeCare has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Healthcare Providers & Services company?
The median EV-to-EBITDA among Healthcare Providers & Services companies is 10.96, based on 506 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Addus HomeCare's current EV-to-EBITDA of 13.19 is 20.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Addus HomeCare. For the Healthcare Providers & Services industry, the median EV-to-EBITDA is 10.96 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Addus HomeCare's current EV-to-EBITDA is 13.19, which is 28% below median its own 10-year median of 18.27. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Addus HomeCare stock overvalued right now?
Based on GuruFocus' analysis, Addus HomeCare (ADUS) is currently considered Modestly Undervalued. The stock's GF Value™ is $123.98, compared to a current price of $112.08 — trading 9.6% below its estimated fair value. The current EV-to-EBITDA is 13.19, which is 28% below median its 10-year median of 18.27 and 20.3% above the Healthcare Providers & Services industry median of 10.96. Addus HomeCare's overall GF Score™ is 94/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Addus HomeCare (ADUS), the current EV-to-EBITDA is 13.19 as of Jul. 23, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Addus HomeCare (ADUS) Overvalued in 2026?
Based on GuruFocus' analysis, Addus HomeCare stock appears to be undervalued.
The current stock price of $112.08 is trading 9.6% below its estimated GF Value™ of $123.98.
GuruFocus considers Addus HomeCare to be Modestly Undervalued.
Key valuation signals for ADUS:
EV-to-EBITDA: 13.19 (28% below median its 10-year median of 18.27)
GF Value™: $123.98 vs. price of $112.08 (9.6% below fair value)
Industry Position: 20.3% above the Healthcare Providers & Services median (#293 of 506)
No single metric tells the full story. See the ADUS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Addus HomeCare Corp is engaged in the provision of in-home care services. The Company has three reportable segments: Personal Care, Hospice, and Home Health. The Personal Care segment provides non-medical assistance with activities of daily living, mainly to the elderly, chronically ill, and disabled individuals. The Hospice segment provides physical, emotional, and spiritual care for terminally ill patients and their families. The Home Health segment provides medical services to individuals requiring care during illness or recovery. It generates the majority of its revenue from the Personal Care segment.
94GF Score
Get the complete analysis for ADUS
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ADUS has been successfully added to your 
